Novo Nordisk A/S Class B (NOVOb)

742.3
-6.8(-0.91%)
  • Volume:
    948,065
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    720.4 - 754.5
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060534915
  • S/N:1742564000

NOVOb Overview

Prev. Close
749.1
Day's Range
720.4-754.5
Revenue
149.03B
Open
720.5
52 wk Range
475.5-834.5
EPS
21.45
Volume
948,065
Market Cap
1.69T
Dividend (Yield)
10.40
(1.39%)
Average Volume (3m)
2,135,954
P/E Ratio
34.93
Beta
0.83
1-Year Change
56.44%
Shares Outstanding
2,272,115,319
Next Earnings Date
Aug 04, 2022
What is your sentiment on Novo Nordisk B?
or
Vote to see community's results!

Novo Nordisk A/S Class B News

Novo Nordisk A/S Class B Analysis

Novo Nordisk A/S Class B Company Profile

Novo Nordisk A/S Class B Company Profile

Employees
46982
Market
Denmark

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Buy
Technical IndicatorsStrong SellStrong SellSellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy